A Randomized, Investigator-Blinded Comparison of Two Topical Regimens in Fitzpatrick Skin Types III-VI With Moderate to Severe Facial Hyperpigmentation.

CONCLUSION: Both a new HQ-free skincare system and a widely-available HQ-based system improved hyperpigmentation in Fitzpatrick skin types III to VI. Though the HQ-based system produced greater improvement in hyperpigmentation when compared to the HQ-free system, there was no difference in MoPASI scores between the treatment groups. Subjects were satisfied with both treatments and reported only mild to moderate irritation using either system.</p> <p><em>J Drugs Dermatol. 2017;16(11):1127-1132.</em></p>.
PMID: 29141061 [PubMed - in process]

Source: Journal of Drugs in Dermatology - November 17, 2017 Category: Dermatology Tags: J Drugs Dermatol Source Type: research